T2 Biosystems Inc (NASDAQ: TTOO) has reported a loss for its second fiscal quarter (ending June 30) of $-0.66 versus a loss $-0.08 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $-9.33 versus $-4.87 for the same period a year ago.
Recent Price Action
T2 Biosystems Inc (NASDAQ: TTOO) stock suffered a large decline of -6.9% on 7/29/24. The stock closed at $4.74. Moreover, this decline was accompanied by unusually high trading volume at 163% of normal. The stock has declined -6.5% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, TTOO is expected to continue to be a major Value Eraser.
T2 Biosystems is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment